Esophageal capsule endoscopy is a useful tool in patients with hemophilia

Anastasios Koulaouzidis, Yun Lin Ang, Sarah Douglas, John N. Plevris

Research output: Contribution to journalArticlepeer-review


Esophageal capsule endoscopy (ECE) is considered to be an alternative to conventional esophagogastroduodenoscopy (EGD); however, its indications continue to expand. This report presents results from the use of ECE in patients with hemophilia at a tertiary referral academic center over a 7-year period. A total of 16 patients with hemophilia, who were all at risk of new-variant Creutzfeldt-Jakob disease due to previous treatment with UK plasma-derived pooled blood products, underwent a total of 28 ECE examinations. Main outcomes were the diagnostic yield of ECE, requirement for subsequent conventional EGD, and any variceal bleeding episodes during the follow-up period. The overall diagnostic yield was 67.8% (19/28 ECEs). Only one patient underwent conventional EGD, for esophageal biopsies. There were no variceal hemorrhage events in any of the patients on variceal screening follow-up. ECE is a useful and acceptable alternative to conventional endoscopy in selected patient groups (i.e. patients with hemophilia). In this group, ECE can eliminate the need for prior administration of clotting factors.

Original languageEnglish
Pages (from-to)1116-1118
Number of pages3
Issue number12
Publication statusPublished - 6 Aug 2014

Cite this